Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer

NCT05468177 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tongji Hospital

Collaborators